Duopharma Biotech invests USD250,000 in Naluri

In a new bid to spur Malaysia’s digital health growth, Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”), a leading Malaysian pharmaceutical company, has agreed to invest USD250,000 into Naluri Hidup Sdn. Bhd. (“Naluri”) via a Simple Agreement for Future Equity (“SAFE”) on 10 April 2020.

Naluri, a local pioneer in digital therapeutics, has developed a proprietary application platform called “Naluri App”. The “Naluri App” is a digital health platform, which combines behavioural science, data science, as well as digital design, to offer a holistic health management programme for users.

The programme is targeted to improve the health of those with risks of chronic conditions such as diabetes, heart diseases, cancer and mental health.

A key feature of the “Naluri App” is multi-disciplinary professional health coaching by qualified psychologists, dietitians, doctors, pharmacists, fitness coaches and other advisors to provide tailored and personalised coaching in a scalable way through instant messaging.

The professional health coaching is supplemented by digital features including an Artificial Intelligence-powered food journal, a thought journal, a health curriculum of daily modules, and a planner that includes reminders and tracking for medication adherence.

Leonard Ariff Abdul Shatar, Group Managing Director of Duopharma Biotech Bhd

Commenting on this new initiative, Duopharma Biotech’s Group Managing Director, Leonard Ariff Abdul Shatar, said that one of the Group’s primary strategies is the innovative use of emerging technologies to provide smarter solutions for a healthier life for all.

“We are confident that Naluri’s concept and platform will be seamlessly integrated into its Specialty and Consumer Healthcare businesses and help to offer premium health packages for its customers,” he said.

He also added that the importance of good health has never been so dramatically demonstrated as in the current global pandemic.

“As encouraged by the Government, I am heartened to see many instances in our nation of a more collaborative approach, which is fundamental to better empower us all to overcome current challenges.”

In a statement, Azran Osman Rani, Naluri’s Chief Executive Officer adds, “We are excited with this strategic partnership with Duopharma Biotech as it enables us to enhance Naluri’s capabilities to serve specific chronic disease therapeutic areas to build an evidence-base of repeatable health improvements”.

Duopharma Biotech is proud to be leading an investment into Naluri, together with other international and local venture capital firms and private investors.

This round brings Naluri’s total funding to over USD3 million to date. This is ahead of the next proposed equity fund raising event expected by early 2021.

This investment constitutes another milestone in Duopharma Biotech’s strategy to innovate and adopt emerging technologies such as digital therapeutics into its portfolio of offering.

Duopharma Biotech intends to develop various use cases utilising Naluri’s technology platform for its Specialty businesses areas such as Diabetes, Renal, Oncology and Cardiology as well as Consumer Health Care business.


Please enter your comment!
Please enter your name here

Latest News

Jeffrey Cheah Foundation to launch endowment fund

Malaysia’s largest education-focused social enterprise Jeffrey Cheah Foundation, has announced its plan to launch an endowment fund. The endowment fund targets to...

Ferrari Malaysia introduces the SF90 Stradale

Naza Italia, official importer and distributor of the Ferrari brand in Malaysia, has launched the highly anticipated SF90 Stradale, in conjunction with...

MARii signs MoU with Persona to develop human capital development programme

The Malaysia Automotive, Robotics and IoT Institute (MARii) and Persona Energy Sdn. Bhd. (Persona) has inked a Memorandum of Understanding (MoU) to...

Service sectors record 1,316 approved projects with investments of RM28.6 billion.

From January to June 2020, the nation's services sectors recorded 1,316 approved projects with investments of RM28.6 billion. These...

Manufacturing sector attracts largest portion of approved investments for 1H2020

Malaysia recorded a total of RM64.8 billion worth of investments in the manufacturing, services and primary sectors for the first six months...

Must read

Empowering Malaysians to become informed investors one app at a time

With a goal to build 500 applications that focuses on enabling action, Reactive Labs, co-founded by George and Riza, aims to go...

Bigo Live: A growing sensation in an industry with a big appetite

The live-streaming industry has seen a massive growth in years. From the likes of Vimeo to Facebook Live, the industry has grown...

Embed a proper digital literacy lesson in the school curriculum

By Afifah Suhaimi Amidst the drastic growth of internet users this year – with almost one million additions compared...

How to hire talent in a post Covid-19 world

According to the Global Startup Ecosystem Report from Start-up Genome, 72 percent of startups saw an average of 32 percent fall in...